304results about How to "Relieve inflammation" patented technology

The invention discloses a polypeptide composition capable of effectively improving acne and repairing skin damage. The polypeptide composition comprises antibacterial polypeptides, polypeptides capable of inhibiting inflammatory response and / or polypeptides capable of promoting collagen and keratin regeneration and repairing acne marks. The polypeptide composition has the advantages that the growth and propagation of propionibacterium acnes and staphylococcus aureus can be inhibited, inflammatory response can be inhibited, edema and couperose skin can be prevented, corium layer collagen synthesis is increased, the regeneration and reinforcing of dermal-epidermis junction (DEJ) area structure tissue can be promoted, epidermis cell differentiation and maturation can be promoted, acne marks can be effectively repaired, and effective acne improving and skin damage repairing can be achieved.

The present invention discloses a topical composition consisting of combinations of mineral oil, vegetable shortening, vitamin E, purified water and other ingredients to form useful therapeutic, dermatological, pharmaceutical, medical or cosmetic compositions for treatment of skin maladies and disorders, namely eczema.

The invention relates to the application of a mannose-enriched polysaccharide to drug preparation, in particular to the application of a mannose-enriched modified polysaccharide to the preparation of drugs for preventing colonitis from cancerization. Aiming to make up the blank of the drugs for preventing the inflammatory bowel diseases and especially the ulcerative colitis from cancerization, the application provides the technical proposal that the mannose-enriched modified polysaccharide is applied to the drugs for preventing the colonitis from cancerization, and the modified polysaccharide contains a modified natural gum or a modified plant polysaccharide. The application has the characteristics that a mannose receptor (MR) is taken as a target; the mannose-enriched polysaccharide is separated and extracted from a medicinal plant, and mannosidase is adopted for hydrolyzation; mannose residues are exposed, and regulate gut immunity and relieve the intestinal inflammation after being combined with the MR on the surface of immunological cells, thereby preventing the inflammatory bowel diseases and especially the ulcerative colitis from cancerization. After the mannose-enriched modified polysaccharide is used on a big mouse suffering from the ulcerative colitis, the cancerization inhibitory rate of the ulcerative colitis can reach 93 percent.

The invention discloses a healthcare agent for pet joints and belongs to the technical field of feed additives. The healthcare agent uses chondroitin sulfate, glucosamine hydrochloride, dimethyl sulfone and collagen as the core components and vitamins and mineral elements as the auxiliary materials and is applicable to pets with arthritis, caused by excessively fast growth and development or maldevelopment, movement damage, senile joint degeneration and the like, of different degrees. The healthcare agent can promote bone health, increase pet immunity, improve pet bone joint diseases and increase pet living quality.